Why GlycoMimetics Stock Is Trading Higher Monday
Why GlycoMimetics Stock Is Trading Higher Monday
GlycoMimetics, Inc. (NASDAQ:GLYC) stock is moving higher Monday after its chief medical officer disclosed the purchase of company stock.
GlycoMimetics, Inc.（納斯達克股票代碼：GLYC）的股價週一走高，此前該公司首席醫療官披露了對公司股票的收購。
The Details: On Tuesday, the chief medical officer Edwin Rock disclosed in a Form4 that he bought 305,000 shares of the company.
詳情：週二，首席醫療官埃德溫·洛克在Form4中透露，他購買了該公司的30.5萬股股票。
Rock purchased the shares at an average price of 26 cents.
洛克以26美分的平均價格購買了這些股票。
How To Buy GlycoMimetics Stock
如何購買 GlycoMimetics 股票
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like GlycoMimetics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投資者在決定股票是否值得買入時可以做出一些決定。除了可以在Benzinga的報價頁面（例如GlycoMimetics的頁面）上找到的估值指標和價格走勢外，還有一些因素，例如公司是否每季度支付股息或購買大部分股票。
These are known as capital allocation programs. GlycoMimetics (NASDAQ:GLYC) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
這些被稱爲資本分配計劃。GlycoMimetics（納斯達克股票代碼：GLYC）不支付股息，但顯然有幾種方法可以向股東返還價值。您可以隨時在Benzinga的股息日曆中搜索下一家即將派發股息的公司，並確定持有該公司股份可以獲得什麼樣的收益率。
For example, if you're looking to earn an annualized return of 21.91%, you'll need to buy a share of Simplify Exchange Traded Funds Simplify Propel Opportunities ETF by the Jun. 25, 2024. Once done, you can expect to receive a nominal payout of $1.25 on Jun. 28, 2024.
例如，如果您希望獲得21.91％的年化回報率，則需要在2024年6月25日之前購買簡化交易所交易基金簡化推動機會ETF的股份。完成後，您預計將在2024年6月28日收到1.25美元的名義補助金。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on GlycoMimetics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回購計劃顯然是不同的，而且變化很大。公司可以批准回購計劃，並在回購獲得批准的時間內酌情購買股票。查看有關GlycoMimetics的最新消息通常可以得出該公司最近是否批准了回購計劃。回購計劃通常作爲股價的支撐，作爲需求的支撐。
Related Link: 5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
相關鏈接：本週有5只具有關鍵催化劑的生物科技股：默沙東、Intellia、維羅納等
GLYC Price Action: At the time of publication, GlycoMimetics shares is trading 20% higher at 32 cents, according to data from Benzinga Pro.
GLYC價格走勢：根據Benzinga Pro的數據，截至發佈時，GlycoMimetics的股價上漲了20％，至32美分。
Image: 8676549 from Pixabay.
圖片：來自Pixabay的8676549。